Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers
L K
LK
University of Tennessee, Memphis 38163, USA. lmyers@utmem.edu
Tang
B
B
Brand
D D
DD
Rosloniec
E F
EF
Stuart
J M
JM
Kang
A H
AH
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000276:immunology; D002417:Cattle; D024043:Collagen Type II / Q000276:immunology / Q000627:therapeutic use*; D016207:Cytokines / Q000276:immunology; D015536:Down-Regulation; D015798:HLA-DR1 Antigen / Q000276:immunology; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D009154:Mutation; D018418:Th2 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D024043:Collagen Type II; D016207:Cytokines; D015798:HLA-DR1 Antigen